Lytgobi Tablet
Product Images NDC 64842-0127

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lytgobi (NDC 64842-0127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Taiho Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Blister Card 4mg 21ct)

LYTGOBI 4 mg tablets prescription drug packaging label by Taiho Pharmaceutical Co., Ltd. The label shows a 7-day blister pack with tablets organized by day, each day containing two tablets. The box includes dosing instructions and emphasizes 4 mg per tablet strength for oral administration of futibatinib tablets.*

FDA Label Image

Principal Display Panel (Blister Card 4mg 28ct)

Packaging label for LYTGOBI (futibatinib) tablets, 4 mg strength by Taiho Pharmaceutical Co., Ltd. The label displays a seven-day blister pack with individual compartments for each day labeled DAY 1 to DAY 7. Instructions at the bottom advise swallowing tablets whole and state a daily dose of 16 mg, taken as four 4 mg tablets once daily.*

FDA Label Image

Principal Display Panel (Blister Card 4mg 35ct)

LYTGOBI (futibatinib) 4 mg tablets packaging label featuring a blister card with seven vertical columns labeled Day 1 through Day 7, each containing four round tablets. The label includes dosage instructions and is marked as prescription only. The labeler is TAIHO PHARMACEUTICAL CO., LTD.*

FDA Label Image

Principal Display Panel (Carton 4mg 21ct)

LYTGOBI (futibatinib) 4 mg tablets packaging label showing a 12 mg daily dose composed of three 4 mg tablets taken orally once daily. The labeler is Taiho Pharmaceutical Co., Ltd. The package contains one blister card with 21 tablets, a 7-day supply. Instructions for opening the card and basic usage guidance are also included.*

FDA Label Image

Principal Display Panel (Carton 4mg 28ct)

LYTGOBI (futibatinib) tablets packaging label for a 16 mg daily dose, containing 4 mg tablets. The label includes instructions to take four 4 mg tablets orally once daily. It shows a blister card containing 28 tablets, a 7-day supply, with manufacturer and labeler information as Taiho Oncology, Inc. The packaging also illustrates the opening mechanism with push and pull instructions.*

FDA Label Image

Principal Display Panel (Carton 4mg 35ct)

Packaging label for LYTGOBI (futibatinib) tablets, 4 mg strength. The label shows a 7-day supply blister card containing 35 tablets. It includes dosing information stating a 20 mg daily dose as five 4 mg tablets taken orally once daily. The labeler is Taiho Pharmaceutical Co., Ltd. The label includes opening instructions with illustrations and dosage advice.*

FDA Label Image

Futibatinib Str (Futibatinib Str)

Chemical structure of futibatinib, the active ingredient in LYTGOBI tablets by Taiho Pharmaceutical Co., Ltd. The diagram shows the molecular arrangement with labeled atoms and bonds indicating its chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.